{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T14:26:49Z","timestamp":1793629609300,"version":"4.5.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim Corp USA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["184.034.014"],"award-info":[{"award-number":["184.034.014"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["918.15.608"],"award-info":[{"award-number":["918.15.608"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["SFRH\/ BD \/93526\/2013"],"award-info":[{"award-number":["SFRH\/ BD \/93526\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jaut.2024.103219","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T23:51:51Z","timestamp":1714521111000},"page":"103219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Impaired LAIR-1-mediated immune control due to collagen degradation in fibrosis"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3187-2288","authenticated-orcid":false,"given":"Tiago","family":"Carvalheiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wioleta","family":"Marut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. In\u00eas","family":"Pascoal Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devan","family":"Fleury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alsya J.","family":"Affandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniek S.","family":"Meijers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Giovannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph G.","family":"Tieland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline","family":"Elshof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ottria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Cossu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Meizlish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tineke","family":"Veenendaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Ramanujam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel E.","family":"Moreno-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Klumperman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalan","family":"Liv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.D.J.","family":"Radstake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linde","family":"Meyaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2024.103219_bib1","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005058","article-title":"Extracellular matrix degradation and remodeling in development and disease","volume":"3","author":"Lu","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jaut.2024.103219_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1146\/annurev-immunol-061020-053734","article-title":"Tissue homeostasis and inflammation","volume":"39","author":"Meizlish","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jaut.2024.103219_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ni.3320","article-title":"Tissue biology perspective on macrophages","volume":"17","author":"Okabe","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2024.103219_bib4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2024.103219_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mam.2018.06.003","article-title":"Organ and tissue fibrosis: molecular signals, cellular mechanisms and translational implications","volume":"65","author":"Weiskirchen","year":"2019","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.jaut.2024.103219_bib6","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41584-019-0322-7","article-title":"Shared and distinct mechanisms of fibrosis","volume":"15","author":"Distler","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103219_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.jaut.2024.103219_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.addr.2017.07.014","article-title":"The good and the bad collagens of fibrosis - their role in signaling and organ function","volume":"121","author":"Karsdal","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jaut.2024.103219_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2015.11.001","article-title":"Extracellular matrix structure","volume":"97","author":"Theocharis","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jaut.2024.103219_bib10","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis--a common pathway to organ injury and failure","volume":"372","author":"Rockey","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2024.103219_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcdb.2019.12.010","article-title":"TGF-beta1 - a truly transforming growth factor in fibrosis and immunity","volume":"101","author":"Lodyga","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.jaut.2024.103219_bib12","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2024.103219_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jaut.2024.103219_bib14","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41584-019-0212-z","article-title":"Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis","volume":"15","author":"Kania","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103219_bib15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2024.103219_bib16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1242\/jcs.188672","article-title":"The integrin-collagen connection--a glue for tissue repair?","volume":"129","author":"Zeltz","year":"2016","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jaut.2024.103219_bib17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1074-7613(00)80530-0","article-title":"LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes","volume":"7","author":"Meyaard","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2024.103219_bib18","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1084\/jem.20052554","article-title":"Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1","volume":"203","author":"Lebbink","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2024.103219_bib19","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.molimm.2005.01.004","article-title":"The inhibitory leukocyte-associated Ig-like receptor-1 (LAIR-1) is expressed at high levels by human naive T cells and inhibits TCR mediated activation","volume":"42","author":"Maasho","year":"2005","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jaut.2024.103219_bib20","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/eji.200636678","article-title":"Regulated expression of the inhibitory receptor LAIR-1 on human peripheral T cells during T cell activation and differentiation","volume":"37","author":"Jansen","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2024.103219_bib21","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1074\/jbc.RA119.011150","article-title":"Leukocyte-associated immunoglobulin-like receptor 1 inhibits T-cell signaling by decreasing protein phosphorylation in the T-cell signaling pathway","volume":"295","author":"Park","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2024.103219_bib22","first-page":"705","article-title":"Inhibitory receptors CD85j, LAIR-1, and CD152 down-regulate immunoglobulin and cytokine production by human B lymphocytes","volume":"12","author":"Merlo","year":"2005","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jaut.2024.103219_bib23","doi-asserted-by":"crossref","first-page":"E3160","DOI":"10.1073\/pnas.1212753109","article-title":"C1q limits dendritic cell differentiation and activation by engaging LAIR-1","volume":"109","author":"Son","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2024.103219_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015080","article-title":"The immune inhibitory receptor LAIR-1 is highly expressed by plasmacytoid dendritic cells and acts complementary with NKp44 to control IFNalpha production","volume":"5","author":"Bonaccorsi","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2024.103219_bib25","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2119\/molmed.2014.00185","article-title":"C1q-mediated repression of human monocytes is regulated by leukocyte-associated Ig-like receptor 1 (LAIR-1)","volume":"20","author":"Son","year":"2015","journal-title":"Mol Med"},{"key":"10.1016\/j.jaut.2024.103219_bib26","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3389\/fimmu.2020.01793","article-title":"Leukocyte associated immunoglobulin like receptor 1 regulation and function on monocytes and dendritic cells during inflammation","volume":"11","author":"Carvalheiro","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103219_bib27","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.immuni.2021.06.012","article-title":"Homeostatic functions of monocytes and interstitial lung macrophages are regulated via collagen domain-binding receptor LAIR1","volume":"54","author":"Keerthivasan","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2024.103219_bib28","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.4049\/jimmunol.180.3.1662","article-title":"The soluble leukocyte-associated Ig-like receptor (LAIR)-2 antagonizes the collagen\/LAIR-1 inhibitory immune interaction","volume":"180","author":"Lebbink","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2024.103219_bib29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.matbio.2009.03.005","article-title":"Identification of multiple potent binding sites for human leukocyte associated Ig-like receptor LAIR on collagens II and III","volume":"28","author":"Lebbink","year":"2009","journal-title":"Matrix Biol."},{"key":"10.1016\/j.jaut.2024.103219_bib30","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J. Rheumatol."},{"issue":"2013","key":"10.1016\/j.jaut.2024.103219_bib31","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"Classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2024.103219_bib32","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103219_bib33","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/ATVBAHA.117.309253","article-title":"Mice lacking the inhibitory collagen receptor LAIR-1 exhibit a mild thrombocytosis and hyperactive platelets","volume":"37","author":"Smith","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jaut.2024.103219_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/cpim.88","article-title":"Experimental mouse model of bleomycin-induced skin fibrosis","volume":"126","author":"Blyszczuk","year":"2019","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.jaut.2024.103219_bib35","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1002\/art.30612","article-title":"Enhanced secretion of leukocyte-associated immunoglobulin-like receptor 2 (LAIR-2) and soluble LAIR-1 in rheumatoid arthritis: LAIR-2 is a more efficient antagonist of the LAIR-1-collagen inhibitory interaction than is soluble LAIR-1","volume":"63","author":"Olde Nordkamp","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2024.103219_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012174","article-title":"Efficient inhibition of collagen-induced platelet activation and adhesion by LAIR-2, a soluble Ig-like receptor family member","volume":"5","author":"Lenting","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2024.103219_bib37","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.4049\/jimmunol.172.9.5535","article-title":"The mouse homologue of the leukocyte-associated Ig-like receptor-1 is an inhibitory receptor that recruits Src homology region 2-containing protein tyrosine phosphatase (SHP)-2, but not SHP-1","volume":"172","author":"Lebbink","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2024.103219_bib38","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/tra.12557","article-title":"Single organelle dynamics linked to 3D structure by correlative live-cell imaging and 3D electron microscopy","volume":"19","author":"Fermie","year":"2018","journal-title":"Traffic"},{"key":"10.1016\/j.jaut.2024.103219_bib39","first-page":"115","volume":"vol. 34","author":"Varga","year":"2008"},{"key":"10.1016\/j.jaut.2024.103219_bib40","doi-asserted-by":"crossref","first-page":"9825","DOI":"10.1021\/acsnano.7b03150","article-title":"In situ imaging of tissue remodeling with collagen hybridizing peptides","volume":"11","author":"Hwang","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jaut.2024.103219_bib41","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1101\/gad.1653708","article-title":"Role of platelet-derived growth factors in physiology and medicine","volume":"22","author":"Andrae","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.jaut.2024.103219_bib42","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1523-1747.1999.00528.x","article-title":"Animal model of sclerotic skin. I: local injections of bleomycin induce sclerotic skin mimicking scleroderma","volume":"112","author":"Yamamoto","year":"1999","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2024.103219_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063282","article-title":"Serum LAIR-2 is increased in autoimmune thyroid diseases","volume":"8","author":"Simone","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2024.103219_bib44","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/annrheumdis-2011-200837","article-title":"Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage","volume":"71","author":"Manetti","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103219_bib45","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s10875-012-9735-7","article-title":"Matrix metalloproteinases: a review of their structure and role in systemic sclerosis","volume":"32","author":"Peng","year":"2012","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jaut.2024.103219_bib46","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1046\/j.1365-2133.1998.02558.x","article-title":"Circulating type I collagen degradation products: a new serum marker for clinical severity in patients with scleroderma?","volume":"139","author":"Hunzelmann","year":"1998","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2024.103219_bib47","doi-asserted-by":"crossref","first-page":"7145","DOI":"10.1038\/s41598-020-64233-8","article-title":"Type III, IV, and VI collagens turnover in systemic sclerosis - a longitudinal study","volume":"10","author":"Juhl","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2024.103219_bib48","doi-asserted-by":"crossref","first-page":"E175","DOI":"10.1016\/S2665-9913(20)30385-4","article-title":"Circulating collagen neo-epitopes and their role in the prediction of fibrosis in patients with systemic sclerosis: a multicentre cohort study","volume":"3","author":"Dobrota","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jaut.2024.103219_bib49","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/rheumatology\/39.10.1110","article-title":"Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relationship with pulmonary involvement","volume":"39","author":"Scheja","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103219_bib50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bone.2018.09.006","article-title":"Collagen type I degradation fragments act through the collagen receptor LAIR-1 to provide a negative feedback for osteoclast formation","volume":"117","author":"Boraschi-Diaz","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.jaut.2024.103219_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.733561","article-title":"Collagen fragments produced in cancer mediate T cell suppression through leukocyte-associated immunoglobulin-like receptor 1","volume":"12","author":"Vijver","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103219_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179833","article-title":"Role of citrullinated collagen in autoimmune arthritis","volume":"23","author":"Myers","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2024.103219_bib53","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1182\/blood-2009-10-246322","article-title":"Crystal structure and collagen-binding site of immune inhibitory receptor LAIR-1: unexpected implications for collagen binding by platelet receptor GPVI","volume":"115","author":"Brondijk","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2024.103219_bib54","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.1182\/blood-2007-08-108472","article-title":"Identification of a major GpVI-binding locus in human type III collagen","volume":"111","author":"Jarvis","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2024.103219_bib55","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1111\/j.1538-7836.2007.02746.x","article-title":"Collagen promotes sustained glycoprotein VI signaling in platelets and cell lines","volume":"5","author":"Tomlinson","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jaut.2024.103219_bib56","doi-asserted-by":"crossref","first-page":"19781","DOI":"10.1074\/jbc.R109.013219","article-title":"Structural insights into the interactions between platelet receptors and fibrillar collagen","volume":"284","author":"Herr","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2024.103219_bib57","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/jth.13613","article-title":"Clustering of glycoprotein VI (GPVI) dimers upon adhesion to collagen as a mechanism to regulate GPVI signaling in platelets","volume":"15","author":"Poulter","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jaut.2024.103219_bib58","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mam.2017.11.008","article-title":"PDGF in organ fibrosis","volume":"62","author":"Klinkhammer","year":"2018","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.jaut.2024.103219_bib59","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11010-014-2068-5","article-title":"Platelet-derived growth factor-BB induces matrix metalloproteinase-2 expression and rat vascular smooth muscle cell migration via ROCK and ERK\/p38 MAPK pathways","volume":"393","author":"Cui","year":"2014","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.jaut.2024.103219_bib60","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s13277-015-3828-x","article-title":"PDGF-D promotes dermal fibroblast invasion in 3-dimensional extracellular matrix via Snail-mediated MT1-MMP upregulation","volume":"37","author":"Qin","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.jaut.2024.103219_bib61","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/jcp.1041400319","article-title":"Effects of platelet-derived growth factor on bone formation in vitro","volume":"140","author":"Canalis","year":"1989","journal-title":"J. Cell. Physiol."},{"issue":"Pt 11","key":"10.1016\/j.jaut.2024.103219_bib62","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1242\/jcs.113.11.2055","article-title":"Collagen degradation and platelet-derived growth factor stimulate the migration of vascular smooth muscle cells","volume":"113","author":"Stringa","year":"2000","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jaut.2024.103219_bib63","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1091\/mbc.e03-05-0352","article-title":"Mechanism of human dermal fibroblast migration driven by type I collagen and platelet-derived growth factor-BB","volume":"15","author":"Li","year":"2004","journal-title":"Mol. Biol. Cell"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124000532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124000532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:19:10Z","timestamp":1777580350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841124000532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":63,"alternative-id":["S0896841124000532"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103219","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.12.07.471103","asserted-by":"object"}]},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired LAIR-1-mediated immune control due to collagen degradation in fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103219"}}